# China NMPA Product Recall - Muscle Relaxation Module E-NMT-01

Source: https://www.globalkeysolutions.net/records/china_product_recall/ge-healthcare-finland-oy/5a3ad6c1-cc1c-4ae1-81e2-239a25851058/
Source feed: China

> China NMPA product recall for Muscle Relaxation Module E-NMT-01 by GE Healthcare Finland Oy published March 18, 2014. Recall level: . The National Medical Products Administration (NMPA) issued a notice on March 18, 2014, concerning a 

---

## Details

- Record Type: CHINA_PRODUCT_RECALL
- Title: GE Healthcare Finland Oy recalls muscle relaxation modules
- Company Name: GE Healthcare Finland Oy
- Publication Date: 2014-03-18
- Product Name: Muscle Relaxation Module E-NMT-01
- Recall Reason: When the muscle relaxation module version 01 (E-NMT-01) is used with the ElectroSensor, it may cause potential safety issues.
- Discovering Company: GE Healthcare Systems Trade Development (Shanghai) Co., Ltd.
- Manufacturing Company: GE Healthcare Finland Oy
- Summary: The National Medical Products Administration (NMPA) issued a notice on March 18, 2014, concerning a voluntary recall initiated by GE Healthcare Finland Oy. On February 27, 2014, GE Healthcare Systems Trade Development (Shanghai) Co., Ltd. reported a potential safety issue with the Muscle Relaxation Module Version 01 (E-NMT-01) when used with the ElectroSensor. The manufacturer, GE Healthcare Finland Oy, based in Finland, had already commenced a voluntary recall of this product on February 26, 2014.The affected product, an E-NMT-01 Muscle Relaxation Module (Registration No.: CFDA (Imported) No. 20103543328), is typically used with an Anesthesia Monitor (Model: S/5) for monitoring neurophysiological status. While the recall impacted regions including the USA, Canada, and the UK, GE Healthcare confirmed that the specific batches with the potential safety issue were not sold or distributed within China.Consequently, no direct corrective actions were required for products within the Chinese market, as the affected items were not present. However, the NMPA, operating under its regulatory framework, instructed provincial, autonomous region, and municipal food and drug administrations to enhance their supervision and management efforts concerning similar medical devices. This proactive measure aims to ensure ongoing product safety and compliance despite the recall not directly involving China.

Company: https://www.globalkeysolutions.net/companies/ge-healthcare-finland-oy/858eadf0-65d6-4d5f-89c3-37aa5f5b8fa1/